0001193125-14-060724.txt : 20140220 0001193125-14-060724.hdr.sgml : 20140220 20140220161759 ACCESSION NUMBER: 0001193125-14-060724 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140220 DATE AS OF CHANGE: 20140220 GROUP MEMBERS: EDWIN M. KANIA, JR. GROUP MEMBERS: FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC GROUP MEMBERS: NOUBAR B. AFEYAN, PH.D. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Receptos, Inc. CENTRAL INDEX KEY: 0001463729 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264190792 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87460 FILM NUMBER: 14629819 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-652-5700 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.) DATE OF NAME CHANGE: 20090522 FORMER COMPANY: FORMER CONFORMED NAME: Receptor Pharmaceuticals Inc. DATE OF NAME CHANGE: 20090507 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Flagship Ventures Fund 2007, L.P. CENTRAL INDEX KEY: 0001508052 IRS NUMBER: 260552049 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE MEMORIAL DRIVE STREET 2: 7TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-868-1888 MAIL ADDRESS: STREET 1: ONE MEMORIAL DRIVE STREET 2: 7TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 SC 13D/A 1 d678728dsc13da.htm SC 13D/A SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2 – Exit Filing)*

 

 

Receptos, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

756207106

(CUSIP Number)

Noubar B. Afeyan, Ph.D.

Flagship Ventures

One Memorial Drive, 7th Floor

Cambridge, Massachusetts 02142

(617) 868-1888

with a copy to:

Sarah Rothermel, Esq.

Wilmer Cutler Pickering Hale and Dorr LLP

60 State Street

Boston, Massachusetts 02109

(617) 526-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

February 10, 2014

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ¨

 

 

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

 

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

(Continued on following pages)

 

 

 


CUSIP No. 756207106    13D    Page 2 of 10 Pages

 

  (1)   

Names of reporting persons

 

Flagship Ventures Fund 2007, L.P.

  (2)  

Check the appropriate box if a member of a group (see instructions)

 

(a)  ¨        (b)  x

  (3)  

SEC use only

 

  (4)  

Source of funds (see instructions)

 

WC

  (5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e).

 

¨

  (6)  

Citizenship or place of organization.

 

Delaware, United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

 

     (7)    

Sole voting power.

 

0

     (8)   

Shared voting power.

 

1,011,911

     (9)   

Sole dispositive power.

 

0

   (10)   

Shared dispositive power.

 

1,011,911

(11)  

Aggregate amount beneficially owned by each reporting person.

 

1,011,911 (see Attachment A)

(12)  

Check if the aggregate amount in Row (11) excludes certain shares (see instructions).

 

¨

(13)  

Percent of class represented by amount in Row (11).

 

4.56% (see Attachment A)

(14)  

Type of reporting person (see instructions).

 

PN


CUSIP No. 756207106    13D    Page 3 of 10 Pages

 

  (1)   

Names of reporting persons

 

Flagship Ventures 2007 General Partner LLC

  (2)  

Check the appropriate box if a member of a group (see instructions)

 

(a)  ¨        (b)  x

  (3)  

SEC use only

 

  (4)  

Source of funds (see instructions)

 

WC

  (5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e).

 

¨

  (6)  

Citizenship or place of organization.

 

Delaware, United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

 

     (7)    

Sole voting power.

 

0

     (8)   

Shared voting power.

 

1,011,911

     (9)   

Sole dispositive power.

 

0

   (10)   

Shared dispositive power.

 

1,011,911

(11)  

Aggregate amount beneficially owned by each reporting person.

 

1,011,911 (see Attachment A)

(12)  

Check if the aggregate amount in Row (11) excludes certain shares (see instructions).

 

¨

(13)  

Percent of class represented by amount in Row (11).

 

4.56% (see Attachment A)

(14)  

Type of reporting person (see instructions).

 

OO


CUSIP No. 756207106    13D    Page 4 of 10 Pages

 

  (1)   

Names of reporting persons

 

Noubar B. Afeyan, Ph.D.

  (2)  

Check the appropriate box if a member of a group (see instructions)

 

(a)  ¨        (b)  x

  (3)  

SEC use only

 

  (4)  

Source of funds (see instructions)

 

WC

  (5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e).

 

¨

  (6)  

Citizenship or place of organization.

 

United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

 

     (7)    

Sole voting power.

 

0

     (8)   

Shared voting power.

 

1,011,911

     (9)   

Sole dispositive power.

 

0

   (10)   

Shared dispositive power.

 

1,011,911

(11)  

Aggregate amount beneficially owned by each reporting person.

 

1,011,911 (see Attachment A)

(12)  

Check if the aggregate amount in Row (11) excludes certain shares (see instructions).

 

¨

(13)  

Percent of class represented by amount in Row (11).

 

4.56% (see Attachment A)

(14)  

Type of reporting person (see instructions).

 

IN


CUSIP No. 756207106    13D    Page 5 of 10 Pages

 

  (1)   

Names of reporting persons

 

Edwin M. Kania, Jr.

  (2)  

Check the appropriate box if a member of a group (see instructions)

 

(a)  ¨        (b)  x

  (3)  

SEC use only

 

  (4)  

Source of funds (see instructions)

 

WC

  (5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e).

 

¨

  (6)  

Citizenship or place of organization.

 

United States of America

Number of

shares

beneficially

owned by

each

reporting

person

with:

 

     (7)    

Sole voting power.

 

0

     (8)   

Shared voting power.

 

1,011,911

     (9)   

Sole dispositive power.

 

0

   (10)   

Shared dispositive power.

 

1,011,911

(11)  

Aggregate amount beneficially owned by each reporting person.

 

1,011,911 (see Attachment A)

(12)  

Check if the aggregate amount in Row (11) excludes certain shares (see instructions).

 

¨

(13)  

Percent of class represented by amount in Row (11).

 

4.56% (see Attachment A)

(14)  

Type of reporting person (see instructions).

 

IN


CUSIP No. 756207106    13D    Page 6 of 10 Pages

Item 1. Security and Issuer.

This Amendment No. 2 amends, supplements and restates (as applicable) the statement on Schedule 13D filed on May 9, 2013, as amended by the statement on Schedule 13D/A that was filed with the SEC on November 25, 2013 (the “Original Filing”), and relates to the Reporting Persons’ (as defined in Item 2 of the Original Filing) beneficial ownership interest in the common stock, par value $0.001 per share (the “Common Stock”), of Receptos, Inc., a Delaware Corporation (the “Issuer”). The address of the principal executive office of the Issuer is 10835 Road to the Cure, Suite 205, San Diego, California 92121. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms used but not otherwise defined herein have the meanings assigned to such terms in the Original Filing.

This Amendment No. 2 is being filed to reflect certain dispositions of the Issuer’s Common Stock by the Reporting Persons and constitutes an exit filing for the Reporting Persons, whose aggregate beneficial ownership has fallen below 5.0% as a result of such dispositions.

Item 2. Identity and Background.

There are no amendments to Item 2 of the Original Filing.

Item 3. Source and Amount of Funds or Other Consideration.

Item 3 of the Original Filing is hereby amended by inserting the following text after the last paragraph thereof:

“On January 21, 2014, the Reporting Persons sold 180,000 restricted shares of the Issuer’s Common Stock in the over-the-counter market at a weighted average price per share of $39.57.

On February 10, 2014, the Reporting Persons sold 165,000 restricted shares of the Issuer’s Common Stock in the over-the-counter market at a weighted average price per share of $43.83.

On February 11, 2014, the Reporting Persons sold 47,300 restricted shares of the Issuer’s Common Stock in the over-the-counter market at a weighted average price per share of $43.99.

On February 12, 2014, the Reporting Persons sold 207,700 restricted shares of the Issuer’s Common Stock in the over-the-counter market at a weighted average price per share of $43.85.

Following such sales, the Reporting Persons owned, in aggregate, 1,011,911 shares of the Issuer’s Common Stock.”

Item 4. Purpose of Transaction.

There are no amendments to Item 4 of the Original Filing.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Original Filing is hereby amended and restated to read in its entirety as follows:

“The aggregate percentage of shares of Common Stock reported beneficially owned by each person named herein has been determined in accordance with SEC rules and is based upon 22,167,602 shares of the Issuer’s common stock outstanding, as reported in the Issuer’s prospectus filed with the SEC on January 9, 2014 pursuant to Rule 424(b)(4) and the Issuer’s Current Report on Form 8-K, filed with the SEC on January 14, 2014. The applicable SEC rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities and include shares of Common Stock issuable upon the conversion or exercise of other securities that are immediately convertible or exercisable, or are convertible or exercisable within 60 days of the filing of this Report.


CUSIP No. 756207106    13D    Page 7 of 10 Pages

 

A. Flagship Ventures Fund 2007, L.P.

 

  (a) As of the closing of business on November 22, 2013, Flagship Fund was the record owner and beneficial owner of 1,011,911 shares of the Issuer’s Common Stock (the “Record Shares”), representing a beneficial ownership interest of approximately 4.56% of the outstanding shares of Common Stock.

 

  (b)      1.    Sole power to vote or direct vote:      0      
       2.    Shared power to vote or direct vote:      1,011,911      
       3.    Sole power to dispose or direct the disposition:      0      
       4.    Shared power to dispose or direct the disposition:      1,011,911      

 

  (c) The Reporting Persons have not effected any transactions in the Common Stock of the Issuer in the past 60 days, except as described in Item 3 of this Schedule 13D, which is incorporated herein by reference.

 

  (d) Except as disclosed herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by each of the Reporting Persons.

 

  (e) Not applicable.

Please see Attachment A for additional information.

 

B. Flagship Ventures 2007 General Partner LLC

 

  (a) In its capacity as general partner of Flagship Fund, Flagship GP may be deemed to be the beneficial owner of the Record Shares, representing a beneficial ownership interest of approximately 4.56% of the outstanding shares of Common Stock.

 

  (b)      1.    Sole power to vote or direct vote:      0      
       2.    Shared power to vote or direct vote:      1,011,911      
       3.    Sole power to dispose or direct the disposition:      0      
       4.    Shared power to dispose or direct the disposition:      1,011,911      

 

  (c) The Reporting Persons have not effected any transactions in the Common Stock of the Issuer in the past 60 days, except as described in Item 3 of this Schedule 13D, which is incorporated herein by reference.

 

  (d) Except as disclosed herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by each of the Reporting Persons.

 

  (e) Not applicable.

Please see Attachment A for additional information.

 

C. Noubar B. Afeyan, Ph.D.

 

  (a) In his capacity as managing member of Flagship GP, Afeyan may be deemed to be the beneficial owner of the Record Shares, representing a beneficial ownership interest of approximately 4.56% of the outstanding shares of Common Stock.

 

  (b)      1.    Sole power to vote or direct vote:      0      
       2.    Shared power to vote or direct vote:      1,011,911      
       3.    Sole power to dispose or direct the disposition:      0      
       4.    Shared power to dispose or direct the disposition:      1,011,911      

 

  (c) The Reporting Persons have not effected any transactions in the Common Stock of the Issuer in the past 60 days, except as described in Item 3 of this Schedule 13D, which is incorporated herein by reference.


CUSIP No. 756207106    13D    Page 8 of 10 Pages

 

  (d) Except as disclosed herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by each of the Reporting Persons.

 

  (e) Not applicable.

Please see Attachment A for additional information.

 

D. Edwin M. Kania, Jr.

 

  (a) In his capacity as managing member of Flagship GP, Kania may be deemed to be the beneficial owner of the Record Shares, representing a beneficial ownership interest of approximately 4.56% of the shares of Common Stock.

 

  (b)      1.    Sole power to vote or direct vote:      0      
       2.    Shared power to vote or direct vote:      1,011,911      
       3.    Sole power to dispose or direct the disposition:      0      
       4.    Shared power to dispose or direct the disposition:      1,011,911      

 

  (c) The Reporting Persons have not effected any transactions in the Common Stock of the Issuer in the past 60 days, except as described in Item 3 of this Schedule 13D, which is incorporated herein by reference.

 

  (d) Except as disclosed herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by each of the Reporting Persons.

 

  (e) Not applicable.

Please see Attachment A for additional information.”

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

There are no amendments to Item 6 of the Original Filing.

Item 7. Material to be Filed as Exhibits.

The following documents are filed as Exhibits to this Amendment No. 2:

 

Exhibit
Number

  

Exhibit Description

99.1    Joint Filing Agreement (Incorporated by reference to Exhibit 99.1 to the Original Filing filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on May 9, 2013).
99.2    Third Amended and Restated Investors’ Rights Agreement dated February 3, 2012, among the Issuer and the Issuer’s securityholders listed therein (Incorporated by reference to Exhibit 4.3 of the Issuer’s Registration Statement on Form S-1 (File No. 333-187737), filed with the SEC on April 4, 2013).


CUSIP No. 756207106    13D    Page 9 of 10 Pages

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 20, 2014

 

FLAGSHIP VENTURES FUND 2007, L.P.
By:   Flagship Ventures 2007 General Partner LLC,
  its general partner

 

By:  

/s/ Noubar B. Afeyan, Ph.D.

  Name: Noubar B. Afeyan, Ph.D.
  Title: Manager

 

FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC
By:  

/s/ Noubar B. Afeyan, Ph.D.

  Name: Noubar B. Afeyan, Ph.D.
  Title: Manager

 

/s/ Noubar B. Afeyan, Ph.D.

Noubar B. Afeyan, Ph.D.

 

/s/ Edwin M. Kania, Jr.

Edwin M. Kania, Jr.


CUSIP No. 756207106    13D    Page 10 of 10 Pages

ATTACHMENT A

Afeyan and Kania are the managers of Flagship GP, which is the general partner of Flagship Fund. Each of Flagship GP, Afeyan, and Kania may be deemed to possess voting and investment control over the shares of Common Stock held by Flagship Fund, and, accordingly, each of Flagship GP, Afeyan, and Kania may be deemed to have indirect beneficial ownership of such shares.

Each Reporting Person disclaims beneficial ownership of the shares of the Issuer’s Common Stock described in this Schedule 13D, except to the extent of his or its pecuniary interest therein.